Morgan Stanley Finance LLC Files New Securities Offering Prospectus

TL;DR

**Morgan Stanley Finance LLC is issuing new securities, watch for details on the offering.**

AI Summary

Morgan Stanley Finance LLC, a subsidiary of Morgan Stanley, filed a 424B2 prospectus on March 24, 2026, for a new offering under File No. 333-275587-01. This filing, identified as Preliminary Pricing Supplement No. 15,130, indicates that Morgan Stanley Finance LLC is preparing to issue new securities. For investors, this means Morgan Stanley is actively raising capital, which could be used for various corporate purposes, potentially impacting future earnings or debt levels.

Why It Matters

This filing signals Morgan Stanley Finance LLC is issuing new securities, which could dilute existing shareholders or increase the company's debt, but also provides capital for growth or operations.

Risk Assessment

Risk Level: medium — The filing itself is procedural, but the underlying offering could introduce market risk depending on the terms and use of proceeds.

Analyst Insight

Investors should monitor subsequent filings (like a final pricing supplement) to understand the specific terms, size, and type of securities being offered by Morgan Stanley Finance LLC, as this will determine the impact on the parent company, Morgan Stanley.

Key Numbers

• 333-275587-01 — File Number (Identifies the specific securities offering by Morgan Stanley Finance LLC)
• 15,130 — Preliminary Pricing Supplement No. (Indicates a specific tranche or series within the overall offering)

Key Players & Entities

• Morgan Stanley Finance LLC (company) — Filer of the 424B2 prospectus
• Morgan Stanley (company) — Parent company of the Filer
• March 24, 2026 (date) — Filing Date
• 333-275587-01 (dollar_amount) — File Number for the offering
• 15,130 (dollar_amount) — Preliminary Pricing Supplement Number

FAQ

Key Financial Figures

• $1,000 — an Stanley Stated principal amount: $1,000 per security Issue price: $1,000 pe
• $959.10 — ue on the pricing date: Approximately $959.10 per security, or within $25.00 of that
• $25.00 — imately $959.10 per security, or within $25.00 of that estimate. See "Estimated Value
• $1,350 — change Maximum payment at maturity: $1,350 per security (135% of the stated princi
• $1,100 — appreciates 5%, investors will receive $1,100 per security, or 110% of the stated pri
• $150 — 85% of their principal and receive only $150 per security at maturity, or 15% of the
• $332.51 — of the underlier on March 20, 2026 was $332.51. The following graph sets forth the dai

Filing Documents

• ms15130_424b2-10731.htm (424B2) — 176KB
• image1.gif (GRAPHIC) — 13KB
• image2.gif (GRAPHIC) — 98KB
• 0001839882-26-016659.txt ( ) — 331KB

Risk Factors

Risk Factors This section describes the material risks relating to the securities. For further discussion of these and other risks, you should read the section entitled "Risk Factors" in the accompanying product supplement and prospectus. We also urge you to consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities. Risks Relating to an Investment in the Securities The securities do not guarantee the return of any principal and do not pay interest. The terms of the securities differ from those of ordinary debt securities in that they do not guarantee the repayment of any principal and do not pay interest. If the final level is less than the downside threshold level, the payout at maturity will be an amount in cash that is significantly less than the stated principal amount of each security, and you will lose an amount proportionate to the full decline in the level of the underlier over the term of the securities. There is no minimum payment at maturity on the securities, and, accordingly, you could lose your entire initial investment in the securities. The appreciation potential of the securities is limited by the maximum payment at maturity. Where the final level is greater than the initial level, the appreciation potential of the securities is limited by the maximum payment at maturity. Although the leverage factor provides enhanced exposure to any increase in the final level over the initial level, if the underlier appreciates over the term of the securities, under no circumstances will the payment at maturity exceed the maximum payment at maturity. The amount payable on the securities is not linked to the value of the underlier at any time other than the observation date. The final level will be based on the closing level of the underlier on the observation date, subject to postponement for non-trading days and certain market disruption events. Even if the value of the underlier appreci

View Full Filing

View this 424B2 filing on SEC EDGAR